Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes

Claus B. Juhl, Malene Hollingdal, Jeppe Sturis, Grethe Jakobsen, Henrik Agersø, Johannes Veldhuis, Niels Pørksen, Ole Schmitz

Research output: Contribution to journal › Article › peer-review

266 Scopus citations

Fingerprint

Dive into the research topics of 'Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences